medicaid glp-1 coverage Who Gets the Shot? Access by State California Medi-Cal halts GLP-1 obesity

Unlike semaglutide and tirzepatide, which can be compounded because they have FDA-approved reference products, retatrutide has no approved form to compound from

Discussion PCOS is a prevalent, highly heterogeneous condition affecting women of reproductive age, frequently involving metabolic comorbidities

Since none of these new formulations or doses have been through safety trials, providers are effectively performing a massive unsanctioned human trial that is deeply unethical, and illegal, to boot

Medicare (2019-2022) Among Utah Medicare beneficiaries, utilization of non-AOM GLP-1s increased sharply from 91.0 to 157.5 prescriptions per 1,000 members between 2019 and 2022

You should use a sharps container

Association of diabetes with anxiety: a systematic review and meta-analysis